CXCL10 produced by DC1 plays a pivotal role in inducing long-lasting type-1 CTLs that mediate an effective anti-brain tumor immune response

Gary Koharbash , Edward Kastenhuber , Xinmei Zhu , Kotaro Sasaki
Cancer Research 68 261 -261

2008
Isocitrate dehydrogenase mutant glial cell resist natural killer cell cytotoxicity (TUM2P.906)

Gary Kohanbash , Michael Brancho , Nduka Amankulor , Michael Lotze
Journal of Immunology 192

2014
72
2002
Th1-associated micrornas and their use for tumor immunotherapy

Gary Kohanbash , Kotaro Sasaki , Hideho Okada

17
2010
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor

Carl H. June , Jennifer Brogdon , Marcela Maus , John Scholler

102
2014
Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.

Cynthia Brissette-Storkus , Wendy K. Fellows , Audrea Gambotto , Katinka M. Giezeman-Smits
Cancer Research 61 ( 6) 2625 -2631

34
2001
Cytokine Gene Therapy of Gliomas: Induction of Reactive CD4+ T Cells by Interleukin-4-transfected 9L Gliosarcoma Is Essential for Protective Immunity

Cynthia S. Brissette-Storkus , Katinka M. Giezeman-Smits , Michael E. Bozik , Michael T. Lotze
Cancer Research 60 ( 9) 2449 -2457

73
2000
Identification of a Novel HLA-A*0201-restricted, Cytotoxic T Lymphocyte Epitope in a Human Glioma-associated Antigen, Interleukin 13 Receptor α2 Chain

Ian F. Pollack , William H. Chambers , Hideho Okada , Walter J. Storkus
Clinical Cancer Research 8 ( 9) 2851 -2855

119
2002
[Immunotherapy for brain tumor: don't get "Lost in Translation"].

Hideho Okada
No shinkei geka. Neurological surgery 33 ( 5) 433

2005
Interleukin-2: developing additional cytokine gene therapies using fibroblasts or dendritic cells to enhance tumor immunity.

Michael Shurin , Hideaki Tahara , Elaine M. Elder , Michael T. Lotze
The cancer journal from Scientific American 6

32
2000
Dicer-regulated micro RNAs 222 and 339 promote immune-escape of cancer cells through downregulation of ICAM-1

Gary Kohanbash , Robert Sobol , Michael Lotze , Xinmei Zhu
Cancer Research 68 2468 -2468

2008
The evolution of alternative splicing in glioblastoma under therapy.

Susan Chang , Joanna J. Phillips , Aaron A. Diaz , Hideho Okada
Genome Biology 22 ( 1) 1 -15

18
2021
Assessing Oximetry Response to Chimeric Antigen Receptor T-cell Therapy against Glioma with 19F MRI in a Murine Model.

Deanne Lister , Eric T Ahrens , Karen Messer , Fanny Chapelin
Radiology. Imaging Cancer 3 ( 1)

1
2021
Current Advances in Immunotherapy for Glioblastoma

Jennifer L Clarke , Jennifer L Clarke , Hideho Okada , Hideho Okada
Current Oncology Reports 23 ( 2) 21 -21

1
2021
SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma

Olga Troyanskaya , Lia Cardarelli , Ruth Dannenfelser , Anna Celli
Science Translational Medicine 13 ( 591)

4
2021
Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma.

Fredrik J Swartling , Nicole M Nasholm , Pavlina Chuntova , Lawrence Fong
Journal for ImmunoTherapy of Cancer 9 ( 6)

24
2021